The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services

08.04.24 15:13 Uhr

Werte in diesem Artikel
Aktien

94,71 EUR -0,47 EUR -0,49%

22,10 EUR -0,06 EUR -0,27%

287,25 EUR -7,55 EUR -2,56%

151,22 EUR 0,80 EUR 0,53%

Indizes

PKT PKT

PKT PKT

1.616,2 PKT -5,4 PKT -0,33%

18.726,8 PKT -42,2 PKT -0,22%

7.209,4 PKT -16,2 PKT -0,22%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

484,4 PKT -2,1 PKT -0,43%

191,7 PKT -0,8 PKT -0,44%

523,0 PKT -2,5 PKT -0,48%

5.047,0 PKT -27,4 PKT -0,54%

9.979,0 PKT -32,9 PKT -0,33%

18.740,0 PKT -2,0 PKT -0,01%

18.706,2 PKT -51,3 PKT -0,27%

3.431,4 PKT -22,5 PKT -0,65%

18.713,8 PKT 39,6 PKT 0,21%

16.832,6 PKT 37,8 PKT 0,22%

7.451,0 PKT -0,2 PKT 0,00%

15.465,6 PKT -88,8 PKT -0,57%

7.374,0 PKT -23,7 PKT -0,32%

2.535,7 PKT 10,0 PKT 0,40%

5.321,4 PKT 13,3 PKT 0,25%

4.780,5 PKT 1,2 PKT 0,03%

4.529,8 PKT -1,8 PKT -0,04%

3.433,5 PKT -23,8 PKT -0,69%

2.519,4 PKT -17,5 PKT -0,69%

18.744,5 PKT -6,4 PKT -0,03%

For Immediate ReleaseChicago, IL – April 8, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: T-Mobile US, Inc. TMUS, Abbott Laboratories ABT, Palo Alto Networks, Inc. PANW, Enterprise Products Partners L.P. EPD and The PNC Financial Services Group, Inc. PNC.Here are highlights from Friday’s Analyst Blog:Top Analyst Reports for T-Mobile US, Abbott Laboratories and Palo Alto NetworksThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc., Abbott Laboratories and Palo Alto Networks, Inc.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today's research reports here >>>Shares of T-Mobile US have outperformed the Zacks Wireless National industry over the past year (+9.3% vs. +5.3%). The company is witnessing top line expansion backed by industry-leading postpaid customer growth with a record-low churn rate.Declining operating expenses are boosting the operating margin. Its Ultra Capacity 5G delivers superfast speeds, powering 5G smartphones and enabling innovators to deliver transformational 5G experiences. During the fourth quarter, T-Mobile added 1.6 million postpaid net customers, while postpaid net account additions were a staggering 299,000.However, the highly competitive and saturated U.S. telecom market lowers its growth potential. Promotional offers and low-priced service plans to expand the customer base are putting pressure on its profitability. The residual value of the surrendered phones, which the companies look to sell in other markets, may induce liquidity risk if the plan falls apart.(You can read the full research report on T-Mobile US here >>>)Abbott Laboratories' shares have outperformed the Zacks Medical - Products industry over the past year (+7.8% vs. +3.8%). The company's pipeline is generating several new growth prospects, which will help sustain the positive momentum and contribute to the strong growth projection in 2024.Alinity, the company's next-generation suite of systems, is a key driver in the core lab diagnostics business. EPD's impressive stretch of strong performance stems from the company's unique business model. Freestyle Libre CGM device is also on a great trajectory, continually outpacing market growth.Within Nutrition, after a period of hiccups, Abbott has finally reestablished itself as the market leader in the infant formula business, underscoring strong customer confidence in the company's products. However, the slump in COVID-19 testing-related sales is hurting Abbott's overall growth. Tough macro conditions also pose a concern for its operations.(You can read the full research report on Abbott Laboratories here >>>)Shares of Palo Alto Networks have gained +36.6% over the past year against the Zacks Internet - Software industry's gain of +63.3%. The company's softening IT spending amid macroeconomic headwinds might hurt its near-term prospects. Forex headwinds and higher marketing and sales expenses are likely to continue hurting its profitability. Also, high acquisition-related expenses are denting margins.Nevertheless, Palo Alto has been benefiting from continuous deal wins and the increasing adoption of its next-generation security platforms, attributable to the rise in the hybrid work environment and the heightened need for stronger security.PANW's strong back-to-back quarterly performances reflect its sustained focus on product innovation, a shift in its business model to subscription-based services, platform integration and continued investments in the go-to-market strategy. The normalization of the supply chain is also aiding growth across the Products, Services and Subscription segments.(You can read the full research report on Palo Alto Networks >>>)Other noteworthy reports we are featuring today include Enterprise Products Partners L.P. and The PNC Financial Services Group, Inc..Why Haven't You Looked at Zacks' Top Stocks? Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com                                      https://www.zacks.com                                                   Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report The PNC Financial Services Group, Inc (PNC): Free Stock Analysis Report Enterprise Products Partners L.P. (EPD): Free Stock Analysis Report Palo Alto Networks, Inc. (PANW): Free Stock Analysis Report T-Mobile US, Inc. (TMUS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Abbott Laboratories

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Abbott Laboratories

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Quelle: Zacks

Nachrichten zu Deutsche Telekom AG

Analysen zu Deutsche Telekom AG

DatumRatingAnalyst
20.05.2024Deutsche Telekom BuyGoldman Sachs Group Inc.
20.05.2024Deutsche Telekom BuyGoldman Sachs Group Inc.
20.05.2024Deutsche Telekom OutperformBernstein Research
17.05.2024Deutsche Telekom BuyDeutsche Bank AG
17.05.2024Deutsche Telekom OutperformBernstein Research
DatumRatingAnalyst
20.05.2024Deutsche Telekom BuyGoldman Sachs Group Inc.
20.05.2024Deutsche Telekom BuyGoldman Sachs Group Inc.
20.05.2024Deutsche Telekom OutperformBernstein Research
17.05.2024Deutsche Telekom BuyDeutsche Bank AG
17.05.2024Deutsche Telekom OutperformBernstein Research
DatumRatingAnalyst
12.05.2021Deutsche Telekom Equal weightBarclays Capital
21.04.2021Deutsche Telekom Equal weightBarclays Capital
22.03.2021Deutsche Telekom Equal weightBarclays Capital
09.03.2021Deutsche Telekom Equal weightBarclays Capital
26.02.2021Deutsche Telekom Equal weightBarclays Capital
DatumRatingAnalyst
30.03.2020Deutsche Telekom UnderweightBarclays Capital
18.03.2020Deutsche Telekom UnderweightBarclays Capital
04.03.2020Deutsche Telekom UnderweightBarclays Capital
20.02.2020Deutsche Telekom verkaufenBarclays Capital
19.02.2020Deutsche Telekom UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Deutsche Telekom AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"